Shi‐Jun Yue

4.6k total citations
139 papers, 3.5k citations indexed

About

Shi‐Jun Yue is a scholar working on Molecular Biology, Complementary and alternative medicine and Plant Science. According to data from OpenAlex, Shi‐Jun Yue has authored 139 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Molecular Biology, 39 papers in Complementary and alternative medicine and 36 papers in Plant Science. Recurrent topics in Shi‐Jun Yue's work include Traditional Chinese Medicine Analysis (25 papers), Ginseng Biological Effects and Applications (21 papers) and Pharmacological Effects of Natural Compounds (20 papers). Shi‐Jun Yue is often cited by papers focused on Traditional Chinese Medicine Analysis (25 papers), Ginseng Biological Effects and Applications (21 papers) and Pharmacological Effects of Natural Compounds (20 papers). Shi‐Jun Yue collaborates with scholars based in China, Canada and United States. Shi‐Jun Yue's co-authors include Yuping Tang, Jin‐Ao Duan, Chang‐Yun Wang, Fei‐Fei Liu, Nehad M. Alajez, Cheng Peng, Wuwen Feng, Rui‐Jia Fu, Angela Bik‐Yu Hui and Brian O’Sullivan and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Shi‐Jun Yue

135 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shi‐Jun Yue China 32 2.1k 597 536 536 419 139 3.5k
Hua Yu China 33 1.8k 0.9× 347 0.6× 400 0.7× 445 0.8× 321 0.8× 121 3.9k
Vivek R. Yadav United States 28 1.7k 0.8× 394 0.7× 340 0.6× 318 0.6× 311 0.7× 60 3.5k
Bonglee Kim South Korea 39 2.5k 1.2× 555 0.9× 480 0.9× 545 1.0× 624 1.5× 283 5.3k
Kishore Banik India 35 2.0k 1.0× 522 0.9× 519 1.0× 258 0.5× 353 0.8× 46 3.7k
Shu‐Chen Chu Taiwan 33 1.6k 0.8× 606 1.0× 312 0.6× 270 0.5× 477 1.1× 96 3.7k
Qing‐Yi Lu United States 38 1.5k 0.7× 478 0.8× 310 0.6× 236 0.4× 559 1.3× 110 4.3k
Youwei Xu China 43 2.4k 1.2× 338 0.6× 631 1.2× 313 0.6× 451 1.1× 119 4.4k
Tae Cheon Jeong South Korea 36 2.2k 1.0× 402 0.7× 811 1.5× 319 0.6× 465 1.1× 181 4.5k
Katrin Sak India 37 2.8k 1.3× 608 1.0× 397 0.7× 427 0.8× 729 1.7× 125 5.9k
Abdul Quaiyoom Khan Qatar 34 1.3k 0.6× 353 0.6× 460 0.9× 265 0.5× 474 1.1× 66 3.1k

Countries citing papers authored by Shi‐Jun Yue

Since Specialization
Citations

This map shows the geographic impact of Shi‐Jun Yue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shi‐Jun Yue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shi‐Jun Yue more than expected).

Fields of papers citing papers by Shi‐Jun Yue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shi‐Jun Yue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shi‐Jun Yue. The network helps show where Shi‐Jun Yue may publish in the future.

Co-authorship network of co-authors of Shi‐Jun Yue

This figure shows the co-authorship network connecting the top 25 collaborators of Shi‐Jun Yue. A scholar is included among the top collaborators of Shi‐Jun Yue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shi‐Jun Yue. Shi‐Jun Yue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yuhan, Shi‐Jun Yue, Lingyan Yu, et al.. (2025). Regulation and Function of the cGAS-STING Pathway: Mechanisms, Post-Translational Modifications, and Therapeutic Potential in Immunotherapy. Drug Design Development and Therapy. Volume 19. 1721–1739. 12 indexed citations
2.
Yang, Xinyu, Shi‐Jun Yue, Wenxiao Wang, et al.. (2024). The identification of metabolites from gut microbiota in coronary heart disease via network pharmacology. Artificial Cells Nanomedicine and Biotechnology. 52(1). 145–155. 3 indexed citations
3.
Ma, Zhaoxia, et al.. (2024). A novel pulmonary fibrosis NOD/SCID murine model with natural aging. BMC Pulmonary Medicine. 24(1). 457–457. 2 indexed citations
4.
Li, Jiajia, Yi Li, Xi Tang, et al.. (2023). Construction of polynary systems by coupling Cd/CdS with magnetic recyclable CuO/Fe2O3/CuFe2O4 nanocomposite for enhancing photo-Fenton degradation of antibiotics. Journal of environmental chemical engineering. 11(5). 111089–111089. 17 indexed citations
5.
Mao, Xi, Ding‐Qiao Xu, Shi‐Jun Yue, et al.. (2023). Potential Medicinal Value of Rhein for Diabetic Kidney Disease. Chinese Journal of Integrative Medicine. 29(10). 951–960. 5 indexed citations
7.
Zhang, Shuo, Zhen Yang, Shi‐Jun Yue, et al.. (2022). When and How Will the Epidemic of COVID-19 End?. Aging and Disease. 13(3). 641–641. 3 indexed citations
8.
9.
Zhang, Shuo, et al.. (2022). Efficacy and Safety of “Three Chinese Patent Medicines and Three TCM Prescriptions” for COVID-19: A Systematic Review and Network Meta-Analysis. Evidence-based Complementary and Alternative Medicine. 2022. 1–16. 10 indexed citations
10.
Gao, Huan, Shi‐Jun Yue, Dongyan Guo, et al.. (2022). Oral Bioavailability-Enhancing and Anti-obesity Effects of Hydroxysafflor Yellow A in Natural Deep Eutectic Solvent. ACS Omega. 7(23). 19225–19234. 5 indexed citations
11.
Bai, Xue, Rui‐Jia Fu, Shuo Zhang, et al.. (2021). Potential medicinal value of celastrol and its synthesized analogues for central nervous system diseases. Biomedicine & Pharmacotherapy. 139. 111551–111551. 29 indexed citations
12.
Xu, Ding‐Qiao, Shi‐Jun Yue, Yan‐Yan Chen, et al.. (2020). Deciphering the Active Compounds and Mechanisms of Qixuehe Capsule on Qi Stagnation and Blood Stasis Syndrome: A Network Pharmacology Study. Evidence-based Complementary and Alternative Medicine. 2020(1). 5053914–5053914. 7 indexed citations
14.
Huang, Lu, Ding‐Qiao Xu, Yan‐Yan Chen, Shi‐Jun Yue, & Yuping Tang. (2020). Leonurine, a potential drug for the treatment of cardiovascular system and central nervous system diseases. Brain and Behavior. 11(2). e01995–e01995. 35 indexed citations
15.
Shi, Xu-Qin, Shi‐Jun Yue, Yuping Tang, et al.. (2019). A network pharmacology approach to investigate the blood enriching mechanism of Danggui buxue Decoction. Journal of Ethnopharmacology. 235. 227–242. 103 indexed citations
16.
Xin, Lan-Ting, Lu Liu, Chang‐Lun Shao, et al.. (2017). Discovery of DNA Topoisomerase I Inhibitors with Low-Cytotoxicity Based on Virtual Screening from Natural Products. Marine Drugs. 15(7). 217–217. 23 indexed citations
18.
Qu, Cheng, Linyan Wang, Hang Lin, et al.. (2016). Hierarchical identification of bioactive components in a medicinal herb by preparative high-performance liquid chromatography and selective knock-out strategy. Journal of Pharmaceutical and Biomedical Analysis. 135. 206–216. 15 indexed citations
19.
Hui, Angela Bik‐Yu, Jeff Bruce, Nehad M. Alajez, et al.. (2011). Significance of Dysregulated Metadherin and MicroRNA-375 in Head and Neck Cancer. Clinical Cancer Research. 17(24). 7539–7550. 78 indexed citations
20.
Alajez, Nehad M., Michelle Lenarduzzi, Emma Ito, et al.. (2011). miR-218 Suppresses Nasopharyngeal Cancer Progression through Downregulation of Survivin and the SLIT2-ROBO1 Pathway. Cancer Research. 71(6). 2381–2391. 241 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026